TH89977B - Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it - Google Patents

Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it

Info

Publication number
TH89977B
TH89977B TH601004999A TH0601004999A TH89977B TH 89977 B TH89977 B TH 89977B TH 601004999 A TH601004999 A TH 601004999A TH 0601004999 A TH0601004999 A TH 0601004999A TH 89977 B TH89977 B TH 89977B
Authority
TH
Thailand
Prior art keywords
iwabradine
delta
substance
preparation
mixtures containing
Prior art date
Application number
TH601004999A
Other languages
Thai (th)
Other versions
TH89977A (en
Inventor
นางสาวมารี-โนแอล โอกุส นายเจราร์ด ดาเมียง นายสตีเฟน ฮอร์วาธ
Original Assignee
เลส์ ลาบอราตัวเรส์ แซร์วีแยร์
Filing date
Publication date
Application filed by เลส์ ลาบอราตัวเรส์ แซร์วีแยร์ filed Critical เลส์ ลาบอราตัวเรส์ แซร์วีแยร์
Publication of TH89977B publication Critical patent/TH89977B/en
Publication of TH89977A publication Critical patent/TH89977A/en

Links

Abstract

รูปฟอร์มผลึก เดลตาd ของไอวาบราดีน ไฮโดรคลอไรด์ของสูตร (I) (สูตรเคมี) (l), แสดงลักษณะเฉพาะจากไดอะแกรมการเลี้ยวเบนรังสี X แบบผงของมัน: Iwabradine delta d form The hydrochloride of formula (I) (chemical formula) (l), characterizes from its powder X-ray diffraction diagram:

Claims (1)

1. รูปฟอร์มผลึก เดลตาd ของไอวาบราดีน ไฮโดรคลอไรด์ของสูตร (I) (สูตรเคมี) (l), แสดงลักษณะเฉพาะจากไดอะแกรมการเลี้ยวเบนรังสี X แบบผงดังต่อไปนี้, วัดโดยใช้เครื่องวัดการ เลี้ยวเบน PANalytical X'Pert Pro ควบคู่กับ เครื่องตรวจหา X'Celertor และ แสดงค่าในเทอมของ ตำแหน่งไลน์ (มุม 2 ธีต้า Bragg's แสดงค่าในหน่วยองศา) ความสูงไลน์ (แสดงค่าในหน่วยนับ), พื้นที่บริเวณไลน์ (แสดงค่าในหน่วยน:1.Iwabradine's delta d form The hydrochloride of the formula (I) (chemical formula) (l), characterizes from the powder X-ray diffraction diagram as follows, measured using the PANalytical X'Pert Pro diffraction meter together with the instrument. Detects X'Celertor and displays value in term of line position (Bragg's 2 theta angle showing value in degrees), line height (displayed in units), line area (Show values in units:
TH601004999A 2006-10-10 Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical composition containing it TH89977A (en)

Publications (2)

Publication Number Publication Date
TH89977B true TH89977B (en) 2008-06-10
TH89977A TH89977A (en) 2008-06-10

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20080406T3 (en) Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
HRP20080417T5 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
HRP20080418T5 (en) CRYSTAL FORM OF BETA-D IVABRADINE HYDROCHLORIDE, PROCEDURE FOR PREPARING IT AND THE PHARMACEUTICAL MIXTURES CONTAINED BY
TW200640873A (en) &bgr-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
WO2007038138A3 (en) Amido compounds and their use as pharmaceuticals
TW200630347A (en) Quinazoline derivatives
NO20085066L (en) 4,5-diphenyl-pyrimidinyl-amino-substituted carboxylic acids, process for their preparation and use thereof as medicaments
WO2006012226A3 (en) N-substituted piperidines and their use as pharmaceuticals
EP1713773A4 (en) N-BENZYL-3,4-DIHYROXYPYRIDINE-2-CARBOXAMIDE AND N-BENZYL-2,3-DIHYDROXYPYRIDINE-4-CARBOXAMIDE COMPOUNDS USEFUL AS INHIBITORS OF HIV INTEGRASE
TW200738658A (en) Novel compounds
TW200602338A (en) Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions
EP2535329A3 (en) Spiro-piperidine derivatives
Chen et al. Discovery of 2-chloro-N-((4, 4-difluoro-1-hydroxycyclohexyl) methyl)-5-(5-fluoropyrimidin-2-yl) benzamide as a potent and CNS penetrable P2X7 receptor antagonist
TW200628466A (en) Quinazoline derivatives
IL192954A (en) Choline salt of 4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-n-(2,2-difluoro-ethyl)-benzamide and compositions thereof
EP2518082A3 (en) Means for the inhibition of anti-beta1-adrenergic receptor antibodies
WO2008017863A3 (en) Crystal structure of p53 mutants and their use
DE602005019722D1 (en) SUBSTITUTED PYRROLIDIN-2-ONE
Oliveira et al. Sibutramine hydrochloride monohydrate: thermal behavior, decomposition kinetics and compatibility studies
WO2006128268A8 (en) Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases
AU2021107491A4 (en) Novel UV-Visible Spectrophotometer methods for detection of Propranolol HCl from sustained release pellets formulations
TH81391B (en) Iwabradine hydrochloride Bd crystal form, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
Ogita et al. Comparison of physical properties and drug-releasing characteristics of white petrolatums
TH122312A (en) Diketopiperazine derivatives, pharmaceutical compositions containing these substances and their medical uses.
Sukumaran et al. Design and evaluation of amine-functionalized salicylic acid loaded hollow mesoporous silica nanoparticles for treatment of triple-negative breast cancer